Description Overview DSIP (Delta Sleep Inducing Peptide) is an endogenous research peptide consisting of nine amino acids (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that was originally isolated from cerebral venous blood of sleeping rabbits
10.26402/jpp.2018.3.11 10 BedekovicV.MiseS.AnicT.StaresinicM.GjurasinM.KopljarM.et al (2003)
10.1124/mol.105.013185
Analysing coronal brain sections taken at 4 mm relative to the ac 49 enabled investigation of motor-related brain areas important for PD pathogenesis, including the caudate (Cd) and putamen (Put), the precentral gyrus (PrG, where the primary motor cortex is located), and the internal and external segments of the globus pallidus (GPi/GPe)
Cost-benefit analysis Research cagrilintide monotherapy: Cost: $800-1,600/month Weight loss: 10-12% over 68 weeks Total investment: $12,000-24,000 (18 months) Per pound lost (220 lb person, 24 lbs): $500-1,000/lb CagriSema combination: Cagrilintide: $800-1,600/month Semaglutide: $150-300/month Total: $950-1,900/month Weight loss: 15-25% (33-55 lbs for 220 lb person) Total investment: $14,000-28,000 (18 months) Per pound lost: $250-850/lb Better value than monotherapy Comparison to bariatric surgery: Surgery: $15,000-25,000 upfront Weight loss: 25-35% One-time cost Permanent anatomical change CagriSema approaching surgery results without surgery Making it more affordable: Use maintenance doses after titration (lower cost) Consider semaglutide alone initially (cheaper, effective) Add cagrilintide if plateau Budget long-term (12-18 months minimum) Use our peptide cost calculator at SeekPeptides to budget your weight loss protocol accurately
